JBIO

Jade Biosciences, Inc. Common Stock
JBIO

Overview Fund Activity

51 hedge funds and large institutions have $396M invested in Jade Biosciences, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 25 reducing their positions, and 2 closing their positions.

Holders
51
Holders Change
+5
Holders Change %
+10.87%
% of All Funds
0.86%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.1%
New
9
Increased
7
Reduced
25
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VA
1
VR Adviser
New York
$9.23M
2
LCM
2
Lynx1 Capital Management
Puerto Rico
$2.99M
3
Skandinaviska Enskilda Banken (SEB)
3
Skandinaviska Enskilda Banken (SEB)
Sweden
$882K
4
PL
4
Parkwood LLC
Ohio
$507K
5
Nuveen Asset Management
5
Nuveen Asset Management
Illinois
$606K

Top Sellers

1
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$41.2M
2
CAM
2
Cormorant Asset Management
Massachusetts
$27.1M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$9.92M
4
BlackRock
4
BlackRock
New York
$11M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$6.92M
Name Market Value Shares Shares
Change 		Shares
Change %
Allspring Global Investments
51
Allspring Global Investments
North Carolina
– – -953 Closed
EI
52
Ellevest Inc
New York
$0 13 – –
CFGS
53
Concourse Financial Group Securities
Alabama
– – – –
CS
54
Credit Suisse
Switzerland
$0 11 +11 –
1 2
3